REWIND: Post ad hoc analysis – total CV or fatal events in people with type 2 diabetes and CV risk factors treated with dulaglutide
BMC CV Diabetology
GR Dagenais, L Ryden, LA Leiter, M Lakshmanan, L Dyal, S Hall, P Pais, HM Colhoun, MC Riddle, HC Gerstein et al
November 2020